Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amphastar Pharmaceuticals Inc (AMPH) vs VanEck Rare Earth/Strategic Metals (REMX) Price & Performance

Amphastar Pharmaceuticals IncTrade
VanEck Rare Earth/Strategic MetalsTrade

Price performance (Past 24H)

Key statistics

Amphastar Pharmaceuticals Inc vs VanEck Rare Earth/Strategic Metals — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $868.62M), while VanEck Rare Earth/Strategic Metals trades at $77.5. The key difference: VanEck Rare Earth/Strategic Metals is trading nearer its 52-week high, Amphastar Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.

AMPHREMX
Market Cap
$868.62M
Sector
HealthSector/Thematic
52-Week High
$30.81$109.53
52-Week Low
$16.87$56.60
Enterprise Value
$1.27B

Returns comparison

Trailing returns across standard periods

About Amphastar Pharmaceuticals Inc

Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.

Read more on AMPH

About VanEck Rare Earth/Strategic Metals

REMX invests in global companies involved in producing, refining, and recycling rare earth and strategic metals. It provides targeted exposure to critical minerals used in high-tech and green energy, with top holdings like Albemarle and Pilbara Minerals.

Read more on REMX